Page 13 - Research Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Impax Asset Management Group plc decreased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 64.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,115 shares of the medical research company’s stock after […]

Harbor Investment Advisory LLC lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 944 shares of the medical research company’s stock after purchasing an additional […]

Dumont & Blake Investment Advisors LLC cut its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,353 shares of the medical research company’s stock after […]

Dumont & Blake Investment Advisors LLC cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,353 shares of the medical research company’s stock after selling 135 shares during […]

Bell Bank lowered its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,716 shares of the medical research company’s stock after selling 146 shares during the quarter. Bell […]